AU2003229263A1 - Specific gene expression in colonic cancer cell lines - Google Patents

Specific gene expression in colonic cancer cell lines

Info

Publication number: AU2003229263A1
Authority: AU; Australia
Prior art keywords: cell lines; gene expression; cancer cell; specific gene; colonic cancer
Prior art date: 2002-03-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003229263A

Other versions

AU2003229263A8 (en

Inventor

Andreas Block

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Universitatsklinikum Hamburg Eppendorf

Original Assignee

Universitatsklinikum Hamburg Eppendorf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-05

Filing date

2003-03-04

Publication date

2003-09-16

2003-03-04 Application filed by Universitatsklinikum Hamburg Eppendorf filed Critical Universitatsklinikum Hamburg Eppendorf

2003-09-16 Publication of AU2003229263A8 publication Critical patent/AU2003229263A8/en

2003-09-16 Publication of AU2003229263A1 publication Critical patent/AU2003229263A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4727—Mucins, e.g. human intestinal mucin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Virology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003229263A 2002-03-05 2003-03-04 Specific gene expression in colonic cancer cell lines Abandoned AU2003229263A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE2002109451 DE10209451A1 (en)	2002-03-05	2002-03-05	Specific gene expression in colon carcinoma cell lines
DE10209451.9		2002-03-05
PCT/DE2003/000669 WO2003074692A2 (en)	2002-03-05	2003-03-04	Specific gene expression in colonic cancer cell lines

Publications (2)

Publication Number	Publication Date
AU2003229263A8 AU2003229263A8 (en)	2003-09-16
AU2003229263A1 true AU2003229263A1 (en)	2003-09-16

Family

ID=27762662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003229263A Abandoned AU2003229263A1 (en)	2002-03-05	2003-03-04	Specific gene expression in colonic cancer cell lines

Country Status (3)

Country	Link
AU (1)	AU2003229263A1 (en)
DE (1)	DE10209451A1 (en)
WO (1)	WO2003074692A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1737966E (en)	2004-04-02	2012-08-06	Univ Texas	Cancer specific promoters
CN108531458A (en) *	2018-04-27	2018-09-14	赛诺（深圳）生物医药研究有限公司	Treat the genetic engineering natural killer cells product of tumour

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005502645A (en) *	2001-08-08	2005-01-27	ザボードオブリージェンツ，ザユニバーシティオブテキサスシステム	Method for amplifying expression from a cell-specific promoter

2002
- 2002-03-05 DE DE2002109451 patent/DE10209451A1/en not_active Withdrawn
2003
- 2003-03-04 AU AU2003229263A patent/AU2003229263A1/en not_active Abandoned
- 2003-03-04 WO PCT/DE2003/000669 patent/WO2003074692A2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2003229263A8 (en)	2003-09-16
WO2003074692A3 (en)	2003-12-18
WO2003074692A2 (en)	2003-09-12
DE10209451A1 (en)	2003-09-18

Publication	Publication Date	Title
AU2002211313A1 (en)	2002-04-15	Gene expression profiles in liver cancer
AU3316600A (en)	2000-09-21	Gene expression in bladder tumors
AU2002352799A1 (en)	2003-06-10	Methods for evaluating drug-resistance gene expression in the cancer patient
AU2003220387A1 (en)	2003-10-08	Gene amplification in cancer
AU1922301A (en)	2001-05-30	Differential gene expression in cancer
AU2003216977A1 (en)	2003-09-04	Cell delivery system
AU2003260351A1 (en)	2004-03-19	Cell culture insert
PL376971A1 (en)	2006-01-23	Amplified genes involved in cancer
AU2003290432A1 (en)	2004-07-22	T cell activating gene
AU2003224598A1 (en)	2003-09-02	Differentially-regulated prostate cancer genes
AUPR311601A0 (en)	2001-03-08	Matrix gene expression in chondrogenesis
AUPS198302A0 (en)	2002-06-06	Improvements in bowsprits
AU8026300A (en)	2001-04-23	Sodd gene expression in cancer
AU2003217222A1 (en)	2003-09-02	In vivo gene transfer
AU2003212826A1 (en)	2003-09-02	Cancer genes
AU2003227861A1 (en)	2003-10-27	Protein involved in cancer
AU2003229263A1 (en)	2003-09-16	Specific gene expression in colonic cancer cell lines
AU2003269557A1 (en)	2004-05-04	Gene families associated with cancers
AU2002364077A1 (en)	2003-07-30	Gene expression profiles in stomach cancer
AU2003275946A1 (en)	2004-05-25	Gene expression in biological conditions
AU2003300328A1 (en)	2004-07-29	Fanc gene mutations in cancer
AU2003252034A1 (en)	2004-02-09	Genes differentially expressed in breast cancer
AU2003239679A1 (en)	2003-12-02	Improvements in greetins cards
AU4462600A (en)	2000-11-14	Novel prostate-restricted gene expressed in prostate cancer
AU2003226557A1 (en)	2003-11-03	Differentially expressed genes in conjunctivial pterygium

Legal Events

Date	Code	Title	Description
2005-01-06	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase